A collection of prominent healthcare interests were among the donors to President Donald Trump’s inaugural fund. | The pharma ...

Equities research analysts at Zacks Research lowered their Q2 2025 earnings estimates for Elevance Health in a research ...

We took advantage of Elevance Health's share price weakness in the fourth quarter and added modestly to our investment. Click ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neurosense Therapeutics Ltd. (NRSN – Research Report), ...

Good morning, and welcome to Elevance Health fourth quarter 2024 earnings call. My name is Nathan Rich, vice president of ...

Investment analysts at Leerink Partnrs dropped their Q3 2025 EPS estimates for shares of Elevance Health in a research note ...

Health insurance provider Elevance Health (NYSE:EVH) in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per share was in line with analysts’ consensus ...

Medicaid managed care organizations, including Elevance Health, Centene and UnitedHealth Group, are working with states to secure rates that account for sicker patients.

Elevance Health released fourth-quarter earnings that topped analyst expectations, sending its stock higher in pre-market ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $492.5, with a ...

Elevance Health (ELV – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Scott Fidel from ...